10 results
P
Signet ring cell carcinoma (SC) patients
I/C
KRAS, BRAF, P53 statuses, and microsatellite instability (MSI), classic adenocarcinoma (AC) and non-SC (including those with SC components < 50%)
O
association with MSI, BRAF mutation, and negative association with KRAS mutation, P53 gene mutations, and P53 protein
P
5,859 patients
I/C
percutaneous approach (PC), surgical cut-down (SC)
O
major vascular complications, major bleeding, perioperative mortality, urgent surgical repair, stroke, myocardial infarction, renal failure, hospital stay, blood transfusion, minor VCs
P
older patients
I/C
subcutaneous (SC) hydration, intravenous (IV) hydration
O
adverse effects
P
Children born through Assisted Reproductive Technology (ART)
I/C
Assisted Reproductive Technology (ART), Children spontaneously conceived (SC)
O
Cerebral Palsy (CP)
P
adults
I/C
subclavian venous catheterization via the supraclavicular approach, subclavian venous catheterization via the traditional infraclavicular approach
O
success rate, incidence of malposition, cannulation access time, incidence of pneumothorax, incidence of artery puncture
P
chronic migraineurs
I/C
anti-CGRP mAbs, various doses of anti-CGRP mAbs
O
migraine days, safety and tolerability
P
workers exposed to diesel exhaust
I/C
occupational exposure to diesel exhaust, no association with skin cancer
O
no increased risk of skin cancer
P
adults with type 2 diabetes that was inadequately controlled with 1 to 2 oral antidiabetic drugs
I/C
oral semaglutide (14 mg once daily), subcutaneous semaglutide, dulaglutide, liraglutide
O
cost-utility ratio, glycosylated hemoglobin, weight, systolic blood pressure, quality-adjusted life-year (QALY)
P
People with dementia, Individuals without dementia
I/C
Diagnosis of dementia, Comparison between individuals with different types of dementia and individuals without dementia
O
Mortality rates, Survival time